June 2, 2020
“Pfizer Inc <PFE.N> said on Tuesday it will invest up to $500 million into publicly traded drug developers to fund their treatment candidates and provide access to the U.S. drugmaker’s scientific expertise. Pfizer said it will make non-controlling investments in… Continue Reading…
Recent Comments